HIPAA Considerations for Hematology Referrals: What Providers Need to Know

Product Pricing
Ready to get started? Book a demo with our team
Talk to an expert

HIPAA Considerations for Hematology Referrals: What Providers Need to Know

Kevin Henry

HIPAA

March 14, 2026

6 minutes read
Share this article
HIPAA Considerations for Hematology Referrals: What Providers Need to Know

HIPAA Privacy Rule and Treatment Referrals

When you refer a patient to hematology, the HIPAA Privacy Rule permits sharing Protected Health Information (PHI) for treatment without obtaining patient authorization. This includes exchanging clinical notes, pertinent lab results, imaging, and medication lists needed for diagnosis or care coordination.

Disclosures for treatment differ from payment or operations. Your Notice of Privacy Practices should inform patients that PHI may be used and disclosed for treatment, payment, and health care operations. Always verify the recipient’s identity and role, and document what you sent in the Electronic Health Record (EHR) for traceability.

  • Permitted without authorization: disclosures for treatment between covered entities involved in the patient’s care.
  • Confirm the minimum data needed for care and avoid unrelated details.
  • Validate recipient contact details before sending to prevent misdirected PHI.

Minimum Necessary Standard in Hematology Referrals

The Minimum Necessary Standard generally does not apply to uses or disclosures for treatment between providers. Even so, limiting information to what the hematologist reasonably needs is a sound safeguard that reduces risk and preserves patient trust.

For non-treatment purposes tied to the referral—such as scheduling logistics, benefits checks, or prior authorization—the Minimum Necessary Standard does apply. Share only the demographic or clinical elements required for that specific task.

What to include in a typical hematology referral

  • Referral reason, differential questions, and urgency.
  • Focused history, problem list, allergies, and current medications.
  • Pertinent results: CBC with differential, smear interpretation, iron studies, coagulation panels, relevant pathology, transfusion history.
  • Key imaging or procedures directly relevant to the hematologic issue.
  • Any special risks (e.g., anticoagulation status) the hematologist must know.

Secure Communication Methods for PHI Transmission

Choose transmission methods that protect confidentiality, integrity, and availability of PHI. Combine technical safeguards (encryption, multi-factor authentication) with Administrative Safeguards (policies, access management) and audit trails.

Preferred channels

  • EHR-to-EHR exchange (e.g., Direct secure messaging, HL7/FHIR interfaces) with end-to-end encryption and receipt confirmations.
  • Encrypted email using transport-layer security; ensure a Business Associate Agreement (BAA) with the email or secure messaging vendor.
  • Cloud-based referral platforms that provide encryption, role-based access, audit logs, and user verification—backed by a BAA.
  • Electronic fax services that encrypt in transit and at rest, avoid local printer spools, and maintain delivery logs (with a BAA).

Operational checkpoints

  • Use verified directory entries for receiving clinics; avoid free-form addresses.
  • Double-check patient identifiers and attachments before sending.
  • Avoid standard SMS or personal email; use only sanctioned, monitored channels.
  • Record transmission details in the EHR and reconcile acknowledgments.

Handling Specially Protected Information

Some data demand heightened care. Psychotherapy notes require separate authorization and are rarely needed for hematology. Substance use disorder records (42 CFR Part 2) typically need specific patient consent unless a defined exception applies; confirm before including them in a referral.

Genetic information—such as results for hemoglobinopathies or thrombophilia—constitutes PHI. While it can be shared for treatment, be mindful of additional protections under federal and state law. When state law is stricter (e.g., HIV/STD results), follow the more protective rule and consider segmenting or redacting non-essential elements.

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Practical steps

  • Segment or flag specially protected data in the EHR; include only if directly relevant to the hematology consult.
  • Use data-tagging features (e.g., DS4P) where available to control downstream visibility.
  • If in doubt, obtain patient authorization that clearly describes what will be shared and with whom.

Business Associate Agreements in Referral Processes

A BAA is required with any vendor that creates, receives, maintains, or transmits PHI on your behalf. Common examples in referral workflows include EHR hosting, secure messaging, electronic fax, cloud storage, referral management platforms, and transcription or scanning services.

You do not need a BAA solely to share PHI with another treating provider’s practice; that exchange is covered by the treatment provision. However, if a third-party platform facilitates the referral or stores the data for you, a BAA with that platform is necessary.

What a strong BAA covers

  • Permitted uses and disclosures of PHI and prohibition on unauthorized use.
  • Safeguards, breach reporting timelines, and incident cooperation.
  • Subcontractor “flow-down” obligations.
  • Return or secure destruction of PHI at contract end and ongoing Risk Analysis.

Documentation and Record-Keeping Requirements

Maintain a clear audit trail of each referral. Your EHR should show what was sent, by whom, to whom, when, and how, including attachments. Capture acknowledgments or delivery confirmations when available.

Keep policies and procedures, BAAs, Risk Analysis and risk management plans, workforce training logs, sanctions, and any patient authorizations or revocations. Retain HIPAA-required documentation for at least six years from creation or last effective date.

Accounting and retention pointers

  • Account for disclosures that require authorization or are not for treatment, payment, or operations.
  • Store updated Notices of Privacy Practices and evidence of distribution.
  • Review referral-related policies annually or after significant workflow or technology changes.

Training and Workforce Compliance for HIPAA

Train staff at onboarding and periodically on privacy, security, and referral workflows. Emphasize role-based access, verification of recipients, the Minimum Necessary Standard for non-treatment tasks, and approved transmission channels.

Reinforce secure device practices (encryption, screens locked, no PHI on personal apps), phishing awareness, and reporting of misdirected PHI. Document all training, apply sanctions when policies are violated, and update curricula after your Risk Analysis or incident reviews.

Conclusion

For hematology referrals, HIPAA allows sharing PHI for treatment, but you should still limit to what’s clinically relevant, transmit via secure, documented channels, and handle specially protected data with extra care. Solid BAAs, thorough records, regular training, and continuous Risk Analysis keep your referral process compliant and patient-centered.

FAQs.

What information can be shared without patient authorization during hematology referrals?

You may share PHI needed for treatment—such as referral notes, relevant labs, imaging, pathology, medications, allergies, and transfusion history—without patient authorization. Exclude psychotherapy notes and carefully evaluate whether any 42 CFR Part 2 or specially protected state-law data are necessary; obtain authorization if required.

How should providers secure PHI when referring to hematologists?

Use encrypted EHR-to-EHR exchange, secure messaging, or encrypted email/e-fax supported by BAAs. Verify recipient details, apply role-based access, and maintain audit logs. Record what you sent, confirm delivery, and avoid unapproved channels like standard SMS or personal email.

Are there additional protections for genetic information in referrals?

Yes. Genetic data are PHI and may be shared for treatment, but they carry additional protections under federal and some state laws. Share only what the hematologist needs, segment when possible, and consider obtaining explicit authorization if the information is not strictly required for the consult.

What documentation is required to maintain HIPAA compliance during referrals?

Document referral content, recipients, dates/times, and delivery confirmations within the EHR. Maintain BAAs, policies and procedures, Notices of Privacy Practices, workforce training logs, sanctions, Risk Analysis with mitigation plans, and any patient authorizations or revocations. Retain required records for at least six years.

Share this article

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Related Articles